José Molina

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Venues

PloS one

Antibiotics (Basel, Switzerland)

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ana Casado, Adelina Gimeno, Manuela Aguilar-Guisado, Manuel García, Jesús Francisco Rodríguez, Pedro Antonio Rivas, Claudio Bueno, José Antonio Lepe, Jose-Miguel Cisneros, José Molina
Safety of early oral ambulatory treatment of adult patients with bloodstream infections discharged from the emergency department. Antimicrobial agents and chemotherapy (2023)
José Molina, Clara María Rosso-Fernández, Enrique Montero-Mateos, José Ramón Paño-Pardo, María Solla, Ana Belén Guisado-Gil, Rocío Álvarez-Marín, María Eugenia Pachón-Ibáñez, Adelina Gimeno, Guillermo Martín-Gutiérrez, José Antonio Lepe, Jose-Miguel Cisneros, null null
Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial). PloS one 17 (12) (2022)
José Molina, Clara María Rosso-Fernández, Enrique Montero-Mateos, José Ramón Paño-Pardo, María Solla, Ana Belén Guisado-Gil, Rocío Álvarez-Marín, María Eugenia Pachón-Ibáñez, Adelina Gimeno, Guillermo Martín-Gutiérrez, José Antonio Lepe, Jose-Miguel Cisneros, null null
Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial). PloS one 17 (12) (2022)
José Molina, Clara María Rosso-Fernández, Enrique Montero-Mateos, José Ramón Paño-Pardo, María Solla, Ana Belén Guisado-Gil, Rocío Álvarez-Marín, María Eugenia Pachón-Ibáñez, Adelina Gimeno, Guillermo Martín-Gutiérrez, José Antonio Lepe, Jose-Miguel Cisneros, null null
Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial). PloS one 17 (12) (2022)
José Molina, Clara María Rosso-Fernández, Enrique Montero-Mateos, José Ramón Paño-Pardo, María Solla, Ana Belén Guisado-Gil, Rocío Álvarez-Marín, María Eugenia Pachón-Ibáñez, Adelina Gimeno, Guillermo Martín-Gutiérrez, José Antonio Lepe, Jose-Miguel Cisneros, null null
Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial). PloS one 17 (12) (2022)
José Molina, Clara María Rosso-Fernández, Enrique Montero-Mateos, José Ramón Paño-Pardo, María Solla, Ana Belén Guisado-Gil, Rocío Álvarez-Marín, María Eugenia Pachón-Ibáñez, Adelina Gimeno, Guillermo Martín-Gutiérrez, José Antonio Lepe, Jose-Miguel Cisneros, null null
Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial). PloS one 17 (12) (2022)
Ana Belén Guisado-Gil, Manuela Aguilar-Guisado, Germán Peñalva, José Antonio Lepe, Ildefonso Espigado, Eduardo Rodríguez-Arbolí, José González-Campos, Nancy Rodríguez-Torres, María Isabel Montero-Cuadrado, José Francisco Falantes-González, Juan Luis Reguera-Ortega, María Victoria Gil-Navarro, José Molina, José-Antonio Pérez-Simón, Jose-Miguel Cisneros
Long-Term Impact of an Educational Antimicrobial Stewardship Program on Management of Patients with Hematological Diseases. Antibiotics (Basel, Switzerland) 10 (2) (2021)

José Molina.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

José Molina